Literature DB >> 15341925

Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells.

Won-Young Lee1, Dae-Seog Lim, Si-Hwan Ko, Young-Jae Park, Kang-Sun Ryu, Mi-Young Ahn, Yong-Rok Kim, Dai Woon Lee, Chang-Whan Cho.   

Abstract

The mechanism of cell death by pheophorbide a (Pba) which has been established to be a potential photosensitizer was examined in experimental photodynamic therapy (PDT) on Jurkat cells, a human lymphoid tumor cell line. In 30-60 min after irradiation, Pba treated cells exhibited apoptotic features including membrane blebbing and DNA fragmentation. Pba/PDT caused a rapid release of cytochrome c from mitochondria into the cytosol. Sequentially, activation of caspase-3 and the cleavage of poly ADP-ribose polymerase (PARP) were followed. Meanwhile, no evidence of activation of caspase-8 was indicated in the cells. In experiments with caspase inhibitors, it was found that caspase-3 alone was sufficient initiator for the Pba-induced apoptosis of the cells. Pba specific emission spectra were confirmed in the mitochondrial fraction and the light irradiation caused a rapid change in its membrane potential. Thus, mitochondria were entailed as the crucial targets for Pba as well as a responsible component for the cytochrome c release to initiate apoptotic pathways. Taken together, it was concluded that the mode of Jurkat cell death by Pba/PDT is an apoptosis, which is initiated by mitochondrial cytochrome c release and caspase-3-pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341925     DOI: 10.1016/j.jphotobiol.2004.05.005

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  11 in total

1.  RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids.

Authors:  Zhenlong Zheng; Lianhua Zhu; Xianglan Zhang; Lianhua Li; Sook Moon; Mi Ryung Roh; Zhehu Jin
Journal:  Lasers Med Sci       Date:  2014-06-24       Impact factor: 3.161

2.  Apoptotic effect of pheophorbide a-mediated photodynamic therapy on DMBA/TPA-induced mouse papillomas.

Authors:  Xianglan Zhang; Eun Joo Choi; Zhenlong Zheng; Lianhua Zhu; Sung Bin Cho; Ki-Yoel Kim; Jin Kim; In-Ho Cha
Journal:  Lasers Med Sci       Date:  2014-06-21       Impact factor: 3.161

3.  Pheophorbide a-Mediated Photodynamic Therapy Triggers HLA Class I-Restricted Antigen Presentation in Human Hepatocellular Carcinoma.

Authors:  Patrick Ming-Kuen Tang; Ngoc-Ha Bui-Xuan; Chun-Kwok Wong; Wing-Ping Fong; Kwok-Pui Fung
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

Review 4.  Photodynamic therapy for cancer: Role of natural products.

Authors:  Behzad Mansoori; Ali Mohammadi; Mohammad Amin Doustvandi; Fatemeh Mohammadnejad; Farzin Kamari; Morten F Gjerstorff; Behzad Baradaran; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2019-05-04       Impact factor: 3.631

5.  RUNX3 confers sensitivity to pheophorbide a-photodynamic therapy in human oral squamous cell carcinoma cell lines.

Authors:  Sook Moon; Jung Yoon Bae; Hwa-Kyung Son; Doo Young Lee; Gyeongju Park; Hyun You; Hyojin Ko; Yong-Chul Kim; Jin Kim
Journal:  Lasers Med Sci       Date:  2013-05-23       Impact factor: 3.161

6.  Photodynamic control of human pathogenic parasites in aquatic ecosystems using chlorophyllin and pheophorbid as photodynamic substances.

Authors:  S Wohllebe; R Richter; P Richter; D P Häder
Journal:  Parasitol Res       Date:  2008-11-14       Impact factor: 2.289

7.  Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.

Authors:  Ju Hee Kim; Jae Myung Park; Yoon Jin Roh; In-Wook Kim; Tayyaba Hasan; Myung-Gyu Choi
Journal:  BMC Cancer       Date:  2015-07-07       Impact factor: 4.430

8.  Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer.

Authors:  Sook Moon; Do Kyeong Kim; Jin Kim
Journal:  Oncotarget       Date:  2017-05-23

9.  Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells.

Authors:  Rubén Ruiz-González; Paula Milán; Roger Bresolí-Obach; Juan Carlos Stockert; Angeles Villanueva; Magdalena Cañete; Santi Nonell
Journal:  Cancers (Basel)       Date:  2017-02-17       Impact factor: 6.639

10.  The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.

Authors:  Bo-hyun Choi; In-geun Ryoo; Han Chang Kang; Mi-Kyoung Kwak
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.